-
Science & Research
-
Articles and Presentations
- FDA's Proactive Role in the Development of an Artificial Pancreas for the Treatment of Diabetes Mellitus
- Developing new drugs for the treatment of drug resistant tuberculosis: a regulatory perspective
- Bioinformatics Modernization and the Critical Path to Improved Benefit-Risk Assessment of Drugs
- Metabolomic biomarkers: their role in the critical path
- Assessment of visual performance in the evaluation of new medical products
- Blood safety: Opportunities and challenges addressed through Critical Path research at FDA
- The pharmacology of electrical stimulation in the heart: Where devices meet drugs
-
-